BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 25848941)

  • 1. Lobular breast cancer: incidence and genetic and non-genetic risk factors.
    Dossus L; Benusiglio PR
    Breast Cancer Res; 2015 Mar; 17():37. PubMed ID: 25848941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations.
    Ditchi Y; Broudin C; El Dakdouki Y; Muller M; Lavaud P; Caron O; Lejri D; Baynes C; Mathieu MC; Salleron J; Benusiglio PR
    Breast J; 2019 Jan; 25(1):16-19. PubMed ID: 30414230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.
    Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing incidence rate of invasive lobular breast carcinoma among older women.
    Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
    Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.
    Aceto GM; Solano AR; Neuman MI; Veschi S; Morgano A; Malatesta S; Chacon RD; Pupareli C; Lombardi M; Battista P; Marchetti A; Mariani-Costantini R; Podestà EJ
    Breast Cancer Res Treat; 2010 Aug; 122(3):671-83. PubMed ID: 19851859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland.
    Verkooijen HM; Fioretta G; Vlastos G; Morabia A; Schubert H; Sappino AP; Pelte MF; Schäfer P; Kurtz J; Bouchardy C
    Int J Cancer; 2003 May; 104(6):778-81. PubMed ID: 12640687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
    Rosenberg LU; Magnusson C; Lindström E; Wedrén S; Hall P; Dickman PW
    Breast Cancer Res; 2006; 8(1):R11. PubMed ID: 16507159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
    Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
    Li CI; Anderson BO; Daling JR; Moe RE
    JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk.
    Lei H; Sjöberg-Margolin S; Salahshor S; Werelius B; Jandáková E; Hemminki K; Lindblom A; Vorechovský I
    Int J Cancer; 2002 Mar; 98(2):199-204. PubMed ID: 11857408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer?
    Chikman B; Davidson T; Kais H; Jeroukhimov I; Leshno A; Sandbank J; Halevy A; Lavy R
    Fam Cancer; 2016 Jan; 15(1):41-7. PubMed ID: 26358115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDH1 germline mutations and hereditary lobular breast cancer.
    Corso G; Intra M; Trentin C; Veronesi P; Galimberti V
    Fam Cancer; 2016 Apr; 15(2):215-9. PubMed ID: 26759166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
    Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
    Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.
    Phipps AI; Li CI; Kerlikowske K; Barlow WE; Buist DS
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1643-54. PubMed ID: 20501751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
    Di Meglio A; Freedman RA; Lin NU; Barry WT; Metzger-Filho O; Keating NL; King TA; Sertoli MR; Boccardo F; Winer EP; Vaz-Luis I
    Breast Cancer Res Treat; 2016 Jun; 157(3):587-96. PubMed ID: 27271765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.
    Schrader KA; Masciari S; Boyd N; Salamanca C; Senz J; Saunders DN; Yorida E; Maines-Bandiera S; Kaurah P; Tung N; Robson ME; Ryan PD; Olopade OI; Domchek SM; Ford J; Isaacs C; Brown P; Balmana J; Razzak AR; Miron P; Coffey K; Terry MB; John EM; Andrulis IL; Knight JA; O'Malley FP; Daly M; Bender P; ; Moore R; Southey MC; Hopper JL; Garber JE; Huntsman DG
    J Med Genet; 2011 Jan; 48(1):64-8. PubMed ID: 20921021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
    Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
    Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.
    Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C
    Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.